163 related articles for article (PubMed ID: 36197594)
1. Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy.
Sadegha S; Varshochian R; Dadras P; Hosseinzadeh H; Sakhtianchi R; Mirzaie ZH; Shafiee A; Atyabi F; Dinarvand R
Daru; 2022 Dec; 30(2):331-341. PubMed ID: 36197594
[TBL] [Abstract][Full Text] [Related]
2. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
3. Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging.
Xue S; Wang Y; Wang M; Zhang L; Du X; Gu H; Zhang C
Int J Nanomedicine; 2014; 9():2527-38. PubMed ID: 24904212
[TBL] [Abstract][Full Text] [Related]
4. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
5. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
7. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
8. Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy.
Rezaei Harandi Z; Heidari R; Reiisi S
IEEE Trans Nanobioscience; 2023 Oct; 22(4):872-880. PubMed ID: 37022888
[TBL] [Abstract][Full Text] [Related]
9. Polyethylene Glycol-Chitosan Oligosaccharide-Coated Superparamagnetic Iron Oxide Nanoparticles: A Novel Drug Delivery System for Curcumin Diglutaric Acid.
Sorasitthiyanukarn FN; Muangnoi C; Thaweesest W; Bhuket PRN; Jantaratana P; Rojsitthisak P; Rojsitthisak P
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906490
[TBL] [Abstract][Full Text] [Related]
10.
Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
[TBL] [Abstract][Full Text] [Related]
11. The anticancer effects of biodegradable nanomagnetic dual natural components on the leptin gene expression in lung cancer.
Askari S; Salehi R; Zarghami N; Akbarzadeh A; Rahmati-Yamchi M
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1753-63. PubMed ID: 26593227
[TBL] [Abstract][Full Text] [Related]
12. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
[TBL] [Abstract][Full Text] [Related]
13. Supercritically dried superparamagnetic mesoporous silica nanoparticles for cancer theranostics.
Vaz-Ramos J; Cordeiro R; Castro MMCA; Geraldes CFGC; Costa BFO; Faneca H; Durães L
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111124. PubMed ID: 32600723
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
15. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
[TBL] [Abstract][Full Text] [Related]
16. Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment.
Reczyńska K; Marszałek M; Zarzycki A; Reczyński W; Kornaus K; Pamuła E; Chrzanowski W
Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486431
[TBL] [Abstract][Full Text] [Related]
17. Folic acid decorated magnetic nanosponge: An efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging.
Gholibegloo E; Mortezazadeh T; Salehian F; Forootanfar H; Firoozpour L; Foroumadi A; Ramazani A; Khoobi M
J Colloid Interface Sci; 2019 Nov; 556():128-139. PubMed ID: 31437658
[TBL] [Abstract][Full Text] [Related]
18. Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.
Maboudi SA; Shojaosadati SA; Aliakbari F; Arpanaei A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1485-1492. PubMed ID: 30889683
[TBL] [Abstract][Full Text] [Related]
19. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications.
Yallapu MM; Othman SF; Curtis ET; Bauer NA; Chauhan N; Kumar D; Jaggi M; Chauhan SC
Int J Nanomedicine; 2012; 7():1761-79. PubMed ID: 22619526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
